Literature DB >> 24938431

Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

David Cella1, Seung Choi, Sofia Garcia, Karon F Cook, Sarah Rosenbloom, Jin-Shei Lai, Donna Surges Tatum, Richard Gershon.   

Abstract

BACKGROUND: Although the use of patient-reported outcome measures (PROs) has increased markedly, clinical interpretation of scores remains lacking. We developed a method to identify clinical severity thresholds for pain, fatigue, depression, and anxiety in people with cancer.
METHODS: Using available Patient-Reported Outcomes Measurement Information System (PROMIS) item bank response data collected on 840 cancer patients, symptom vignettes across a range of symptom severity were developed and placed on index cards. Cards represented symptom severity at five-point intervals differences on the T score metric [mean = 50; standard deviation (SD) = 10]. Symptom vignettes for each symptom were anchored on these standardized scores at 0.5 SD increments across the full range of severity. Clinical experts, blind to the PROMIS score associated with each vignette, rank-ordered the vignettes by severity, then arrived at consensus regarding which two vignettes were at the upper and lower boundaries of normal and mildly symptomatic for each symptom. The procedure was repeated to identify cut scores separating mildly from moderately symptomatic, and moderately from severely symptomatic scores. Clinician severity rankings were then compared to the T scores upon which the vignettes were based.
RESULTS: For each of the targeted PROs, the severity rankings reached by clinician consensus perfectly matched the numerical rankings of their associated T scores. Across all symptoms, the thresholds (cut scores) identified to differentiate normal from mildly symptomatic were near a T score of 50. Cut scores differentiating mildly from moderately symptomatic were at or near 60, and those separating moderately from severely symptomatic were at or near 70.
CONCLUSIONS: The study results provide empirically generated PROMIS T score thresholds that differentiate levels of symptom severity for pain interference, fatigue, anxiety, and depression. The convergence of clinical judgment with self-reported patient severity scores supports the validity of this methodology to derive clinically relevant symptom severity levels for PROMIS symptom measures in other settings.

Entities:  

Mesh:

Year:  2014        PMID: 24938431      PMCID: PMC4710358          DOI: 10.1007/s11136-014-0732-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  23 in total

1.  Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain.

Authors:  Mark P Jensen; Douglas G Smith; Dawn M Ehde; Lawrence R Robinsin
Journal:  Pain       Date:  2001-04       Impact factor: 6.961

2.  Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks.

Authors:  William T Riley; Nan Rothrock; Bonnie Bruce; Christopher Christodolou; Karon Cook; Elizabeth A Hahn; David Cella
Journal:  Qual Life Res       Date:  2010-07-01       Impact factor: 4.147

3.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

Review 4.  Electronic patient-reported outcome systems in oncology clinical practice.

Authors:  Antonia V Bennett; Roxanne E Jensen; Ethan Basch
Journal:  CA Cancer J Clin       Date:  2012-07-18       Impact factor: 508.702

5.  Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

Authors:  Diane C Zelman; Ellen Dukes; Nancy Brandenburg; Alan Bostrom; Mugdha Gore
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

6.  Screening for distress in lung and breast cancer outpatients: a randomized controlled trial.

Authors:  Linda E Carlson; Shannon L Groff; Olga Maciejewski; Barry D Bultz
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

7.  Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.

Authors:  Xin Shelley Wang; Fengmin Zhao; Michael J Fisch; Ann M O'Mara; David Cella; Tito R Mendoza; Charles S Cleeland
Journal:  Cancer       Date:  2014-02-01       Impact factor: 6.860

8.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

9.  Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology.

Authors:  Amy P Abernethy; James E Herndon; Jane L Wheeler; Jeannette M Day; Linda Hood; Meenal Patwardhan; Heather Shaw; Herbert Kim Lyerly
Journal:  J Pain Symptom Manage       Date:  2009-04-25       Impact factor: 3.612

10.  Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire.

Authors:  Madeleine T King; David Cella; David Osoba; Martin Stockler; David Eton; Joanna Thompson; Amy Eisenstein
Journal:  Patient Relat Outcome Meas       Date:  2010-09-23
View more
  51 in total

1.  Application of the Patient-Reported Outcomes Measurement Information System (PROMIS) item parameters for Anxiety and Depression in the Netherlands.

Authors:  Jan van Bebber; Gerard Flens; Johanna T W Wigman; Edwin de Beurs; Sjoerd Sytema; Lex Wunderink; Rob R Meijer
Journal:  Int J Methods Psychiatr Res       Date:  2018-09-24       Impact factor: 4.035

2.  United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer.

Authors:  Roxanne E Jensen; Arnold L Potosky; Carol M Moinpour; Tania Lobo; David Cella; Elizabeth A Hahn; David Thissen; Ashley Wilder Smith; Jaeil Ahn; George Luta; Bryce B Reeve
Journal:  J Clin Oncol       Date:  2017-04-20       Impact factor: 44.544

Review 3.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.

Authors:  Roxanne E Jensen; Nan E Rothrock; Esi M DeWitt; Brennan Spiegel; Carole A Tucker; Heidi M Crane; Christopher B Forrest; Donald L Patrick; Rob Fredericksen; Lisa M Shulman; David Cella; Paul K Crane
Journal:  Med Care       Date:  2015-02       Impact factor: 2.983

4.  Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Authors:  Kathryn L Taylor; George Luta; Richard M Hoffman; Kimberly M Davis; Tania Lobo; Yingjun Zhou; Amethyst Leimpeter; Jun Shan; Roxanne E Jensen; David S Aaronson; Stephen K Van Den Eeden
Journal:  Transl Behav Med       Date:  2018-03-01       Impact factor: 3.046

5.  PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients.

Authors:  Kerrie Clover; Sylvie D Lambert; Christopher Oldmeadow; Benjamin Britton; Madeleine T King; Alex J Mitchell; Gregory Carter
Journal:  Qual Life Res       Date:  2018-02-08       Impact factor: 4.147

6.  Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.

Authors:  Karon F Cook; David E Victorson; David Cella; Benjamin D Schalet; Deborah Miller
Journal:  Qual Life Res       Date:  2014-08-23       Impact factor: 4.147

7.  Idio Scale Judgment: evaluation of a new method for estimating responder thresholds.

Authors:  Karon F Cook; Michael A Kallen; Cheryl D Coon; David Victorson; Deborah M Miller
Journal:  Qual Life Res       Date:  2017-06-17       Impact factor: 4.147

8.  Symptom Clusters in Breast Cancer Survivors: A Latent Class Profile Analysis.

Authors:  Lena Lee; Alyson Ross; Kathleen Griffith; Roxanne E Jensen; Gwenyth R Wallen
Journal:  Oncol Nurs Forum       Date:  2020-01-01       Impact factor: 2.172

9.  Responding to the quality imperative to embed mental health care into ambulatory oncology.

Authors:  Frank J Penedo; David Cella
Journal:  Cancer       Date:  2016-11-10       Impact factor: 6.860

10.  Validation of PROMIS emotional distress short form scales for cervical cancer.

Authors:  Justin Wilford; Kathryn Osann; Susie Hsieh; Bradley Monk; Edward Nelson; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2018-08-02       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.